SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001654954-20-004633
Filing Date
2020-04-29
Accepted
2020-04-29 16:17:45
Documents
5
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 NOTICE AND ACCESS CARD ndra_defa14a.htm DEFA14A 39018
2 IMAGE ndra_defa14a.jpg GRAPHIC 8253
3 IMAGE ndra_defa14a000.jpg GRAPHIC 8113
4 IMAGE ndra_defa14a001.jpg GRAPHIC 8542
5 IMAGE ndra_defa14a002.jpg GRAPHIC 8848
  Complete submission text file 0001654954-20-004633.txt   65635
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37969 | Film No.: 20830575
SIC: 3845 Electromedical & Electrotherapeutic Apparatus